LG-2527

LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer, but was never marketed.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer, but was never marketed. It reached the preclinical stage of development prior to the discontinuation of its development in early 2001.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1239044753 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001239044753 · captured 2024-08-06 · ledger · version history

Cite this page as: encyclopegia.org, “LG-2527”, snapshot enwiki-001239044753. https://encyclopegia.org/a/lg-2527

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.